| 产品名称： | J.gamma1 |
|---|---|
| 商品货号： | TS211755 |
| Organism： | Homo sapiens, human |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | clusters in suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | acute T cell leukemia |
| Gender： | male |
| Derivation： | Wild-type Jurkat cells were mutagenized with the frameshifting mutagen ICR-191 and clones were isolated that failed to increase calcium in response to pervanadate. The selection procedure was repeated on the P98 clone to establish the J.gamma1 cell line. |
| Clinical Data： | male |
| Comments： | The J.gamm1 cell line is a phospholipase C-gamma1 (PLC-gamma1) deficient mutant of the E6-1 clone of Jurkat (ATCC TIB-152). The J.gamma1.WT derivative (ATCC CRL-2679) stably expresses PLC-gamma1at levels comparable to the Jurkat cell line. The J.gamma1 subline contains no detectable PLC-gamma1 protein. The lack of PLC-gamma1 expression in J.gamma1 cells causes profound defects in T cell receptor (TCR) calcium mobilization and nuclear factor of activated T-cells (NFAT) activation.
These transcriptional defects are reversed by transfection of P98 cells with a wild-type PLC-gamma1 expression vector.
|
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 105 viable cells/mL.
Maintain cell density between 1 X 105 and 2 to 3 X 106 viable cells/mL. |
| Cryopreservation： | culture medium 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37°C |
| STR Profile： | Amelogenin: X CSF1PO: 11,12 D13S317: 8,12 D16S539: 11 D5S818: 9 D7S820: 8,12 THO1: 6,9.3 TPOX: 8,10 vWA: 18,19 |
| Name of Depositor： | RT Abraham |
| Deposited As： | human |
| References： | Irvin BJ, et al. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol. Cell. Biol. 20: 9149-9161, 2000. PubMed: 11094067 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | J.gamma1 |
|---|---|
| 商品货号： | TS211755 |
| Organism： | Homo sapiens, human |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | clusters in suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | acute T cell leukemia |
| Gender： | male |
| Derivation： | Wild-type Jurkat cells were mutagenized with the frameshifting mutagen ICR-191 and clones were isolated that failed to increase calcium in response to pervanadate. The selection procedure was repeated on the P98 clone to establish the J.gamma1 cell line. |
| Clinical Data： | male |
| Comments： | The J.gamm1 cell line is a phospholipase C-gamma1 (PLC-gamma1) deficient mutant of the E6-1 clone of Jurkat (ATCC TIB-152). The J.gamma1.WT derivative (ATCC CRL-2679) stably expresses PLC-gamma1at levels comparable to the Jurkat cell line. The J.gamma1 subline contains no detectable PLC-gamma1 protein. The lack of PLC-gamma1 expression in J.gamma1 cells causes profound defects in T cell receptor (TCR) calcium mobilization and nuclear factor of activated T-cells (NFAT) activation.
These transcriptional defects are reversed by transfection of P98 cells with a wild-type PLC-gamma1 expression vector.
|
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 105 viable cells/mL.
Maintain cell density between 1 X 105 and 2 to 3 X 106 viable cells/mL. |
| Cryopreservation： | culture medium 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37°C |
| STR Profile： | Amelogenin: X CSF1PO: 11,12 D13S317: 8,12 D16S539: 11 D5S818: 9 D7S820: 8,12 THO1: 6,9.3 TPOX: 8,10 vWA: 18,19 |
| Name of Depositor： | RT Abraham |
| Deposited As： | human |
| References： | Irvin BJ, et al. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol. Cell. Biol. 20: 9149-9161, 2000. PubMed: 11094067 |
